EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Recurrent Pericarditis in a Middle-Aged Female with MEFV Mutation

Xiaohang Liu, Tongxin Xiao iD, Lihua Zhang, Zhongjie Fan iD, Xinglin Yang, Zhuang Tian

Journal of Cardiovascular Development and Disease · 19.05.2026 · 13 (5) · 218

DOI: 10.3390/jcdd13050218 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 19.05.2026. Verfasst von Xiaohang Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100006…. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent pericarditis (RP) remains challenging, especially in tuberculosis (TB)-endemic regions where empirical anti-TB therapy is often unnecessarily prolonged. We report a 35-year-old woman with three RP episodes over six months, presenting with pleuritic chest pain, elevated inflammatory markers, and moderate-to-large pericardial effusion. Extensive infectious (including TB), autoimmune, and malignancy workups were negative. Cardiac magnetic resonance revealed persistent pericardial late gadolinium enhancement despite clinical remission. Whole-exome sequencing identified a heterozygous MEFV c.442G>C (p.Glu148Gln) variant, suggesting an autoinflammatory predisposition. Although the patient finally achieved sustained symptom-free status for six months on a standardized low-dose colchicine regimen, still over 10% of patients have recurrent symptoms receiving colchicine in addition to conventional anti-inflammatory therapy with aspirin or ibuprofen. This case highlights the shifting paradigm from an infection-centered to an autoinflammatory framework for RP in TB-endemic countries, underscores the role of MEFV variants in idiopathic recurrent pericarditis, and illustrates the real-world gap between genetic insights and therapeutic accessibility to IL-1 inhibitors in resource-limited settings.

Schlagwörter

Stichwörter der Autor:innen

MEFV geneautoinflammationrecurrent pericarditistuberculosis

Autor:innen und Institutionen

  • Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100006, China.
  • Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100006, China.
  • Department of Endocrine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100006, China.

ORCID-Profile: Tongxin Xiao, Zhongjie Fan

Förderung

  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Liu, X., Xiao, T., Zhang, L., Fan, Z., Yang, X., & Tian, Z. (2026). Recurrent Pericarditis in a Middle-Aged Female with MEFV Mutation. Journal of Cardiovascular Development and Disease, 13(5), 218. https://doi.org/10.3390/jcdd13050218

Vancouver

Liu X, Xiao T, Zhang L, Fan Z, Yang X, Tian Z. Recurrent Pericarditis in a Middle-Aged Female with MEFV Mutation. Journal of Cardiovascular Development and Disease. 2026;13(5):218. doi:10.3390/jcdd13050218

BibTeX
@article{Liu2026,
  author = {Liu, Xiaohang and Xiao, Tongxin and Zhang, Lihua and Fan, Zhongjie and Yang, Xinglin and Tian, Zhuang},
  title = {Recurrent Pericarditis in a Middle-Aged Female with MEFV Mutation},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {5},
  pages = {218},
  doi = {10.3390/jcdd13050218}
}
Kostenlos starten →